520
Views
7
CrossRef citations to date
0
Altmetric
Original Articles

Molecular basis of arsenite (As+3)-induced acute cytotoxicity in human cervical epithelial carcinoma cells

, , , , , & show all
Article: 26875 | Received 03 Dec 2014, Accepted 20 Mar 2015, Published online: 27 Apr 2015

References

  • Hughes MF, Beck BD, Chen Y, Lewis AS, Thomas DJ. Arsenic exposure and toxicology: a historical perspective. Toxicol Sci. 2011; 123: 305–32.
  • Petrick JS, Ayala-Fierro F, Cullen WR, Carter DE, Vasken Aposhian H. Monomethylarsonous acid (MMA(III)) is more toxic than arsenite in Chang human hepatocytes. Toxicol Appl Pharmacol. 2000; 163: 203–7.
  • Hughes MF. Arsenic toxicity and potential mechanisms of action. Toxicol Lett. 2002; 133: 1–16.
  • Rossman TG. Mechanism of arsenic carcinogenesis: an integrated approach. Mutat Res. 2003; 533: 37–65.
  • Hindmarsh JT, McCurdy RF. Clinical and environmental aspects of arsenic toxicity. Crit Rev Clin Lab Sci. 1986; 23: 315–47.
  • Jha AN, Noditi M, Nilsson R, Natarajan AT. Genotoxic effects of sodium arsenite on human cells. Mutat Res. 1992; 284: 215–21.
  • Stevens JJ, Graham B, Walker AM, Tchounwou PB, Rogers C. The effects of arsenic trioxide on DNA synthesis and genotoxicity in human colon cancer cells. Int J Environ Res Public Health. 2010; 7: 2018–32.
  • Ahmad A, Toor RH, Aftab S, Shakoori AR. Anti-proliferative and genotoxic effect of arsenic and lead on human brain cancer cell line. Pakistan J Zool. 2014; 46: 1069–76.
  • Chou WC, Hawkins AL, Barrett JF, Griffin CA, Dang CV. Arsenic inhibition of telomerase transcription leads to genetic instability. J Clin Invest. 2001; 108: 1541–7.
  • Shen S, Wang C, Weinfeld M, Le XC. Inhibition of nucleotide excision repair by arsenic. Chin Sci Bull. 2013; 58: 214–21.
  • Druwe IL, Vaillancourt RR. Influence of arsenate and arsenite on signal transduction pathways: an update. Arch Toxicol. 2010; 84: 585–96.
  • Levine AJ. p53, the cellular gatekeeper for growth and division. Cell. 1997; 88: 323–31.
  • Magnelli L, Ruggiero M, Chiarugi V. The old and the new in p53 functional regulation. Biochem Mol Med. 1997; 62: 3–10.
  • Bates MN, Smith AH, Hopenhayn-Rich C. Arsenic ingestion and internal cancers: a review. Am J Epidemiol. 1992; 135: 462–76. [PubMed Abstract].
  • Repetto G, del Peso A, Zurita JL. Neutral red uptake assay for the estimation of cell viability/cytotoxicity. Nat Protoc. 2008; 3: 1125–31.
  • Coqueret O. New roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment?. Trends Cell Biol. 2003; 13: 65–70.
  • de Renty C, DePamphilis ML, Ullah Z. Cytoplasmic localization of p21 protects trophoblast giant cells from DNA damage induced apoptosis. PLoS One. 2014; 9: e97434.
  • Ding J, He G, Gong W, Wen W, Sun W, Ning B, etal. Effects of nickel on cyclin expression, cell cycle progression and cell proliferation in human pulmonary cells. Cancer Epidemiol Biomarkers Prev. 2009; 18: 1720–9.
  • Ebert F, Weiss A, Bultemeyer M, Hamann I, Hartwig A, Schwerdtle T. Arsenicals affect base excision repair by several mechanisms. Mutat Res. 2011; 715: 32–41.
  • Ahmad A, Muneer B, Shakoori AR. Effect of chromium, cadmium and arsenic on growth and morphology of HeLa cells. J Basic Appl Sci. 2012; 8: 53–8.
  • Moll UM, Petrenko O. The MDM2-p53 interaction. Mol Cancer Res. 2003; 1: 1001–8. [PubMed Abstract].
  • Estaquier J, Vallette F, Vayssiere JL, Mignotte B. The mitochondrial pathways of apoptosis. Adv Exp Med Biol. 2012; 942: 157–83. [PubMed Abstract].